Singapore: Alcon, global eye care firm, has launched an ophthalmic pharmaceutical manufacturing facility in Singapore to...
Singapore: About 180 million new hospital beds will be needed over the next decade to meet the rising healthcare demand ...
Singapore: Singapore's Health Sciences Authority has signed a memorandum of understanding (MoU) with the National Univer...
Singapore: A new class of ultrasmall peptides developed by A*Star's Institute of Bioengineering and Nanotechnology (IBN)...
Singapore: Mundipharma Ophthalmology Products has announced an agreement with MSD, known as Merck in the United States a...
Singapore: Researchers from A*Star's Institute of Bioengineering and Nanotechnology (IBN) and IBM have unveiled first-e...
Singapore: Pfizer has launched Xalkori, a targeted therapy for ALK-positive non-small cell lung cancer (NSCLC), in Singa...
Singapore: Over the past 15 years, Singapore has developed into a renowned bioscience cluster through top-down investmen...
Singapore: Aslan Pharmaceuticals received approval by the Singapore Health Sciences Authority (HSA) for its Clinical Tri...
Singapore: Covance, a global drug development company, has recieved the 2014 Frost & Sullivan Asia Pacific CRO Growt...
Lack of trained and skilled workforce, identifying a market-savvy work force and retaining the right people on key posit...
Singapore: Boehringer Ingelheim has achieved positive results from the trial of afatinib in comparison to erlotinib in p...
Singapore: ASLAN Pharmaceuticals (ASLAN), a biotech company focused on the development of immunotherapies and targeted a...
Singapore: ICON, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and m...
Singapore: Personalized medicine market will be worth over USD149 billion by 2020, growing at a CAGR of 8.74 percent, an...
Singapore: A team comprising Professor Patrick Tan from Duke-NUS Graduate Medical School (Duke-NUS) and A*STAR's Genome ...
Singapore: A*STAR's Institute of Microelectronics (IME) and SFC Fluidics, a US-based microfluidics and biomedical device...
The sector of life sciences in the Asia Pacific (APAC) region offers massive opportunities for companies, which are look...
